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CASE REPORT Open Access
Percutaneous retrieval of an embolized left
atrial appendage closure device from the
left atrium in a patient with previous
MitraClips
Manik Chopra1, Yam-Hong Wong1,2* , Lars Søndergaard1 and Ole De Backer1
Abstract
Background: Left atrial appendage closure is increasingly used. LAA closure procedures can rarely be complicated
by device embolization, typically towards the aorta. In this case report, we describe the successful percutaneous
retrieval of an embolized Amulet device from the left atrium in a patient with previous MitraClips.
Case presentation: By guidance of intracardiac echocardiography (ICE) and under local anaesthesia, two guiding
systems were introduced into the LA; one to stabilize the device against the lateral LA wall and one large system to
retrieve the device. However, the LAA closure device was finally snared by a three-loop snare and pulled across
the interatrial septum (IAS) without taking the device into a protective guiding sheath – and this without tearing
the IAS.
Conclusions: In conclusion, percutaneous retrieval of an embolized LAA closure device from the LA is feasible by
transseptal approach under local anaesthesia and with ICE guidance.
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Background
Left atrial appendage (LAA) closure is increasingly rec-
ognized as a therapeutic option for patients with atrial
fibrillation (AF) and absolute or relative contraindications
to oral anticoagulation (OAC) [1–3]. Rarely, LAA closure
procedures are complicated by device embolization.
Percutaneus strategies for device retrieval have been
successfully applied and described in earlier case reports,
typically after embolization towards the aorta [4–6]. In
this case report, we describe the successful percutaneous
retrieval of an embolized Amulet device (Abbott, MN,
USA) from the left atrium (LA) in a patient with previous
MitraClips (Abbott, MN, USA).
Case presentation
An 86 year-old male suffering from severe, symptomatic
mitral regurgitation (MR) was referred to our center for
percutaneous mitral valve repair by use of the MitraClip
system – this procedure was performed successfully. As the
patient was also known with permanent AF (CHADSVASc
score of 3) and a history of recurrent bleeding from the rec-
tum (following radiotherapy for prostate carcinoma), a per-
cutaneous LAA closure was proposed to and accepted by
the patient at discharge.
One month after MitraClip treatment, the patient was
hospitalized for the percutaneous LAA closure procedure.
Sizing of the LAA was performed by use of a pre-proced-
ural multi-detector computed tomography (MDCT) scan,
showing a LAA landing zone with a maximal diameter of
36.6mm and a perimeter-derived mean diameter of 33.8
mm (Fig. 1a, b). This was at the upper range of LAA di-
mensions possible to close percutaneously, as the largest
LAA closure device available is the Amulet device of
34mm. Therefore, a particularly distal alternative landing
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zone was selected in an attempt to secure device anchor-
ing. This second landing zone was measured to have a
maximal diameter of 31.2mm and a perimeter-derived
mean diameter of 28.3mm (Fig. 1c, d).
The LAA closure procedure was performed under
local anesthesia and with guidance of intracardiac echo-
cardiography (ICE). Given the LAA morphology and
dimensions as described above, an Amulet device of
31 mm was implanted in this more distal position than
usual in the LAA lobe. The lobe was implanted more
than 2/3 beyond the circumflex artery, there was adequate
compression on the lobe, the lobe was well-aligned with
the axis of the LAA, there was adequate separation of the
lobe and the disc, and the disc was concave-shaped. Also a
gentle tug-test did not change the device position. Conse-
quently, the LAA closure device was released (Fig. 1e).
The patient remained stable during the post-procedural
period; however, a follow-up transthoracic echocardiog-
raphy (TTE) 18 h after the procedure showed device
embolization (Additional file 1: Video S1). The cause of
embolization was probably multifactorial: the trumpet-like
large LAA with a wide ostium, and a short landing zone
combined with a sharply angulated chicken-wing morph-
ology. Since the patient had two MitraClips in place, the
LAA closure device had no chance to migrate towards the
aorta and the device was whirling around in the LA
(Fig. 2a).
A strategy was made to retrieve the device percutan-
eously. The procedure was again performed under local
anaesthesia under ICE guidance. One venous and one
arterial access was made in the left groin, which were
used for ICE and blood pressure monitoring, respect-
ively. Two other venous accesses were taken in the right
groin, in order to have two transseptal accesses into the
LA. The plan was to stabilize the device with a forceps
or snare through a steerable guide (the more inferior
transsepal access) and ultimately snare and retrieve the
device through a 24Fr MitraClip steerable guiding cath-
eter (the more superior transseptal access) (Fig. 2b,
Additional file 2: Video S2). In order to prevent aspir-
ation of air through the MitraClip steerable guide, a
short 16Fr sheath was introduced into the distal end of
the MitraClip steerable guiding catheter.
A forceps and goose-neck snare were not successful to
stabilize the wirling LAA closure device. Ultimately, the
best and easiest strategy was to push the device against
the lateral LA wall by means of a three-loop snare, intro-
duced through the inferior transseptal access. As it
turned out, by coincidence, that the screw on the distal
end of the Amulet lobe presented itself in a very favor-
able way following this maneuver, the device was snared
by means of the three-loop snare and retrieved from the
LA by pulling the device through the transseptal punc-
ture. As the steerable guide (Agilis NxT, Abbott, MN,
USA) only had a 8.5Fr inner lumen, the Amulet device
could not be pulled into this guide. Clearly, this entailed
the (calculated risk) of inducing a major tear in the
interatrial septum (IAS) - however, in such case, this
could have been (most likely) been treated with an atrial
septal defect closure device, which is readily available in
our cathlab.
Following this maneuver, the device was released in
the inferior vena cava (IVC). The MitraClip guiding
catheter was then pulled back to the IVC (Fig. 2c) and
the device was snared into the MitraClip system by use
of a goose-neck snare. ICE showed an intact IAS and no
pericardial effusion. All systems were taken out and the
venous accesses were closed by figure-of-8 suture.
The patient remained hemodynamically stable
throughout the entire procedure and heparin was given
Fig. 1 a-b CT measurements of the usual landing zone, and c-d CT
measurements of a more distal alternative landing zone. e Amulet
LA closure device released with signs of adequate stability and
minimal leakage. CT, computed tomography
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as per ACT (250–300 s) thoughout the procedure. The
patient was stable during the post-procedural period. A
control TTE 24 h after the procedure confirmed an in-
tact IAS and no pericardial effusion (Fig. 2d). The pa-
tient was finally discharged on aspirin 36 h after the
retrieval procedure.
Discussion & Conclusion
When confronted with an embolized LAA closure
device, percutaneous retrieval should be considered. Dif-
ferent techniques of embolized device retrieval have been
well described [7], but an embolized device retained in
the LA due to the presence of Mitraclips is not com-
monly encountered.
In case the LAA closure device migrates towards the
aorta, snaring and retrieval by a retrograde approach
using the femoral artery should be planned. In case the
LAA closure device is caught in the LA, e.g. due to
prior MitraClips, the device can be retrieved by trans-
septal approach. In the latter scenario, two systems
could be introduced into the LA, one to stabilize the
device against the lateral LA wall and one large enough
system (≥ 16 Fr) to retrieve the device. However, in this
specific case, the LAA closure device was pulled across
the IAS without taking the device into a protective
guiding sheath – this was done without damaging or
tearing the IAS. The three-loop snare appeared to be
the better choice for both stabilizing and retrieving the
mobile LAA closure device and the best part of the
Amulet device to snare is the screw on the distal end of
the lobe.
In conclusion, percutaneous retrieval of an embolized
LAA closure device from the LA is feasible by transseptal
approach under local anaesthesia and with ICE guidance.
Additional file
Additional file 1: Video S1. The emolized device whirling in the left
atrium as seen on TTE. (MOV 11281 kb)
Additional file 2: Video S2. The emolized device whirling in the left
atrium as seen on fluoroscopy, with a three-loop snare attempting to
stablize the device. (MOV 34381 kb)
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